Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

TEAD mediates YAP-dependent gene induction and growth control

Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · see citing works

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works

The Hippo pathway and human cancer

Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3458 · Cited by 1,852 · see citing works

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452 · see citing works

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205 · see citing works

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.013 · Cited by 1,094 · see citing works

A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

Roessler, S. K., Jia, H.-L., Budhu, A., Forgues, M., Ye, Q.-H., Lee, J., Thorgeirsson, S. S., Sun, Z., Tang, Z., Qin, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2607 · Cited by 1,047 · see citing works

The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804 · see citing works

Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

Hou, J., Aerts, J. G. J. V., den Hamer, B., van IJcken, W. F. J., den Bakker, M., Riegman, P. H. J., van der Leest, C., van der Spek, P. J., Foekens, J. A., Hoogsteden, H. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010312 · Cited by 758 · see citing works

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

Lamar, J. M., Stern, P., Liu, H., Schindler, J. W., Jiang, Z.-G., & Hynes, R. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212021109 · Cited by 656 · see citing works

Advances in sarcoma genomics and new therapeutic targets

Taylor, B. S., Barretina, J. G., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3087 · Cited by 428 · see citing works

Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma

Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360 · see citing works

Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressorPreprint

Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., et al. (2004) · Genes & Development · doi:10.1101/gad.1200704 · Cited by 358 · see citing works

Rhabdomyosarcomas in Adults and Children: An Update

Parham, D. M., & Ellison, D. A. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1454-riaaca · Cited by 333 · see citing works

Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer

Pass, H. I. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90162-0 · Cited by 298 · see citing works

A spatially and temporally restricted mouse model of soft tissue sarcoma

Kirsch, D. G., Dinulescu, D. M., Miller, J. B., Grimm, J., Santiago, P. M., Young, N. P., Nielsen, G. P., Quade, B. J., Chaber, C. J., Schultz, C. P., et al. (2007) · Nature Medicine · doi:10.1038/nm1602 · Cited by 289 · see citing works

Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis

Eisinger‐Mathason, T. S. K., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M. S., Karakasheva, T. A., Mucaj, V., Shay, J. E. S., Stangenberg, L., Sadri, N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0118 · Cited by 280 · see citing works

YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes

Mizuno, T., Murakami, H., Fujii, M., Ishiguro, F., Tanaka, I., Kondo, Y., Akatsuka, S., Toyokuni, S., Yokoi, K., Osada, H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.5 · Cited by 279 · see citing works

The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism

Chen, X. X., Müller, G. A., Quaas, M., Fischer, M., Han, N., Stutchbury, B., Sharrocks, A. D., & Engeland, K. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00881-12 · Cited by 226 · see citing works

The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members

Mahoney, W. M., Jeong-Ho, H. O. N. G., Yaffe, M. B., & Farrance, I. K. G. (2005) · Biochemical Journal · doi:10.1042/bj20041434 · Cited by 212 · see citing works

FOX(M1) News—It Is Cancer

Halasi, M., & Gartel, A. L. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0712 · Cited by 210 · see citing works

Upstream Operators Enhance Repression of the lac Promoter

Mossing, M. C., & Record, M. T. (1986) · Science · doi:10.1126/science.3090685 · Cited by 197 · see citing works

FoxM1 Is a General Target for Proteasome Inhibitors

Bhat, U. G., Halasi, M., & Gartel, A. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006593 · Cited by 185 · see citing works

FOXM1 (Forkhead box M1) in Tumorigenesis

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 183 · see citing works

The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation

Tremblay, A. M., Missiaglia, E., Galli, G. G., Hettmer, S., Urcia, R., Carrara, M., Judson, R. N., Thway, K., Nadal, G., Selfe, J. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.029 · Cited by 178 · see citing works

Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma

Nakayama, R., Nemoto, T., Takahashi, H., Ohta, T., Kawai, A., Seki, K., Yoshida, T., Toyama, Y., Ichikawa, H., & Hasegawa, T. (2007) · Modern Pathology · doi:10.1038/modpathol.3800794 · Cited by 175 · see citing works

Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma

Seidel, C., Schagdarsurengin, U., Blümke, K., Würl, P., Pfeifer, G. P., Hauptmann, S., Taubert, H. W., & Dammann, R. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20317 · Cited by 155 · see citing works

A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

Gusarova, G. A., Wang, I., Major, M. L., Kalinichenko, V. V., Ackerson, T. J., Petrovic, V., & Costa, R. H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27527 · Cited by 154 · see citing works

Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma

Linehan, D. C., Lewis, J. J., Leung, D. H. Y., & Brennan, M. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1637 · Cited by 152 · see citing works

Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor A

Detwiller, K. Y., Fernando, N. T., Segal, N. H., Ryeom, S. W., D'Amore, P. A., & Yoon, S. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4078 · Cited by 147 · see citing works

High-Frequency Canonical Wnt Activation in Multiple Sarcoma Subtypes Drives Proliferation through a TCF/β-Catenin Target Gene, CDC25A

Vijayakumar, S., Liu, G., Rus, I. A., Yao, S., Chen, Y., Akiri, G., Grumolato, L., & Aaronson, S. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.010 · Cited by 128 · see citing works

Alveolar rhabdomyosarcoma–associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression

Crose, L. E. S., Galindo, K. A., Kephart, J. G., Chen, C., Fitamant, J., Bardeesy, N., Bentley, R. C., Galindo, R. L., Ashley Chi, J.-T., & Linardic, C. M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67087 · Cited by 124 · see citing works

A novel mode of FoxM1 regulation: Positive auto-regulatory loop

Halasi, M., & Gartel, A. L. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8708 · Cited by 122 · see citing works

Haploinsufficiency of the Mouse Forkhead Box f1 Gene Causes Defects in Gall Bladder Development

Kalinichenko, V. V., Zhou, Y., Bhattacharyya, D., Kim, W., Shin, B., Bambal, K., & Costa, R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112162200 · Cited by 117 · see citing works

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

Hélias‐Rodzewicz, Z., Pérot, G., Chibon, F., Ferreira, C., Lagarde, P., Terrier, P., Coindre, J., & Aurias, A. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20825 · Cited by 107 · see citing works

FoxO1 and FoxM1 Transcription Factors Have Antagonistic Functions in Neonatal Cardiomyocyte Cell-Cycle Withdrawal and IGF1 Gene Regulation

Sengupta, A., Kalinichenko, V. V., & Yutzey, K. E. (2012) · Circulation Research · doi:10.1161/circresaha.112.277442 · Cited by 102 · see citing works

p53 negatively regulates expression of FoxM1

Pandit, B., Halasi, M., & Gartel, A. L. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9628 · Cited by 96 · see citing works

An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors

Peng, T., Zhang, P., Liu, J., Nguyen, T. P. T., Bolshakov, S. V., Belousov, R., Young, E. D., Wang, X., Savannah, K. J. B., López-Terrada, D., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.185 · Cited by 87 · see citing works

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells

Lok, G. T. M., Chan, D. W., Liu, V. W. S., Hui, W. W. Y., Leung, T. H. Y., Yao, K., & Ngan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023790 · Cited by 77 · see citing works

Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma

Mito, J. K., Riedel, R. F., Dodd, L. G., Lahat, G., Lazar, A. J., Dodd, R. D., Stangenberg, L., Eward, W. C., Hornicek, F. J., Yoon, S. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008075 · Cited by 74 · see citing works

Photodynamic therapy with verteporfin: A new treatment in ophthalmology

Michels, S., & Schmidt-Erfurth, U. M. (2001) · Seminars in Ophthalmology · doi:10.1076/soph.16.4.201.10298 · Cited by 70 · see citing works

Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4

Wierstra, I., & Alves, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.119 · Cited by 68 · see citing works

Micelle-Encapsulated Thiostrepton as an Effective Nanomedicine for Inhibiting Tumor Growth and for Suppressing FOXM1 in Human Xenografts

Wang, M., & Gartel, A. L. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0536 · Cited by 51 · see citing works

Cooperative Binding of TEF-1 to Repeated GGAATG-Related Consensus Elements with Restricted Spatial Separation and Orientation

Jiang, S., Desai, D. S., Khan, S. R., & Eberhardt, N. L. (2000) · DNA and Cell Biology · doi:10.1089/10445490050128430 · Cited by 45 · see citing works

Histologic and Genetic Advances in Refining the Diagnosis of “Undifferentiated Pleomorphic Sarcoma”

Kelleher, F. C., & Viterbo, A. (2013) · Cancers · doi:10.3390/cancers5010218 · Cited by 40 · see citing works

Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells

Massuda, E., Dunphy, E. J., Redman, R. A., Schreiber, J. J., Nauta, L. E., Barr, F. G., Maxwell, I. H., & Cripe, T. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14701 · Cited by 40 · see citing works

The Role of the Hippo Pathway in Melanocytes and Melanoma

Kim, J. E., Finlay, G. J., & Baguley, B. C. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00123 · Cited by 38 · see citing works

The role of MAPK pathway in bone and soft tissue tumors.

Sasaki, K., Hitora, T., Nakamura, O., Kono, R., & Yamamoto, T. (2011) · PubMed · Cited by 38 · see citing works

Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias

Yoo, N. J., Park, S. W., & Lee, S. H. (2011) · Pathology · doi:10.1097/pat.0b013e32834c3599 · Cited by 18 · see citing works

Soft tissue sarcomas—New approaches to diagnosis and classification

Lauer, S. R., & Gardner, J. M. (2013) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2013.03.001 · Cited by 14 · see citing works

TEAD 2, a Hippo pathway gene, is somatically mutated in gastric and colorectal cancers with high microsatellite instability

Je, E. M., Choi, Y. J., Chung, Y. J., Yoo, N. J., & Lee, S. H. (2014) · Apmis · doi:10.1111/apm.12327 · Cited by 4 · see citing works

YAP/TAZ at the Roots of Cancer

Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970 · see citing works

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860 · see citing works

The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration

Wang, J., Liu, S., Heallen, T. R., & Martin, J. F. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0063-3 · Cited by 383 · see citing works

Coordinating gene expression during the cell cycle

Fischer, M., Schade, A. E., Branigan, T. B., Müller, G. A., & DeCaprio, J. A. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.06.007 · Cited by 218 · see citing works

A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy

Pobbati, A. V., & Hong, W. (2020) · Theranostics · doi:10.7150/thno.40889 · Cited by 223 · see citing works

YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation

Hasegawa, K., Fujii, S., Matsumoto, S., Tajiri, Y., Kikuchi, A., & Kiyoshima, T. (2020) · The Journal of Pathology · doi:10.1002/path.5553 · Cited by 193 · see citing works

FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis

Kalathil, D., John, S., & Nair, S. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.626836 · Cited by 169 · see citing works

The Hippo pathway in normal development and cancer

Maugeri‐Saccà, M., & Maria, R. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.011 · Cited by 165 · see citing works

Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer

Weiler, S. M. E., Pinna, F., Wolf, T., Lutz, T., Geldiyev, A., Sticht, C., Knaub, M., Thomann, S., Bissinger, M., Wan, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.018 · Cited by 155 · see citing works

Intratumoral oxygen gradients mediate sarcoma cell invasion

Lewis, D. M., Park, K. M., Tang, V., Xu, Y., Pak, K., Eisinger‐Mathason, T. S. K., Simon, M. C., & Gerecht, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605317113 · Cited by 125 · see citing works

Advances in sarcoma diagnostics and treatment

Dancsok, A. R., Asleh, K., & Nielsen, T. O. (2016) · Oncotarget · doi:10.18632/oncotarget.12548 · Cited by 118 · see citing works

Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies

Kim, M. H., & Kim, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2412-x · Cited by 98 · see citing works

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

Liu, C., Barger, C. J., & Karpf, A. R. (2021) · Cancers · doi:10.3390/cancers13123065 · Cited by 97 · see citing works

Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis

Huangyang, P., Li, F., Lee, P., Nissim, I., Weljie, A. M., Mancuso, A., Li, B., Keith, B., Yoon, S. S., & Simon, M. C. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.012 · Cited by 93 · see citing works

YAP and TAZ Take Center Stage in Cancer

Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 93 · see citing works

MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues

Gonzalez-Molina, J., Gramolelli, S., Liao, Z., Carlson, J. W., Ojala, P. M., & Lehti, K. (2019) · Cells · doi:10.3390/cells8090991 · Cited by 89 · see citing works

p53 shades of Hippo

Furth, N., Aylon, Y., & Oren, M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.163 · Cited by 87 · see citing works

The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective

Xiao, Y., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13246214 · Cited by 84 · see citing works

TAZ and YAP are frequently activated oncoproteins in sarcomas

Fullenkamp, C. A., Hall, S. L., Jaber, O. I., Pakalniskis, B. L., Savage, E. C., Savage, J. M., Ofori-Amanfo, G. K., Lambertz, A. M., Ivins, S. D., Stipp, C. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8979 · Cited by 78 · see citing works

YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells

Wei, T., Weiler, S. M. E., Tóth, M., Sticht, C., Lutz, T., Thomann, S., Torre, C. D. L., Straub, B. K., Merker, S., Ruppert, T., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0801-y · Cited by 76 · see citing works

USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein

Li, X., Wu, H.-Y., Mao, X.-F., Jiang, L., & Wang, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.040 · Cited by 73 · see citing works

miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance

Guo, Y. X., Cui, J. G., Ji, Z., Cheng, C., Zhang, K., Zhang, C., Chu, M., Zhao, Q., Yu, Z., Zhang, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.240 · Cited by 72 · see citing works

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas

Deel, M. D., Li, J., Crose, L. E. S., & Linardic, C. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00190 · Cited by 71 · see citing works

Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells

Enzo, E., Secone Seconetti, A., Forcato, M., Tenedini, E., Polito, M. P., Sala, I., Carulli, S., Contin, R., Peano, C., Tagliafico, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22779-9 · Cited by 66 · see citing works

FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways

Kelleher, F. C., & O’Sullivan, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8669 · Cited by 63 · see citing works

YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis

Ye, S., Lawlor, M. A., Rivera-Reyes, A., Egolf, S., Chor, S., Pak, K., Ciotti, G. E., Lee, A. C., Marino, G. E., Shah, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4052 · Cited by 63 · see citing works

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex

Merritt, N. M., Garcia, K. C., Rajendran, D., Lin, Z., Zhang, X., Mitchell, K. A., Borcherding, N. C., Fullenkamp, C. A., Chimenti, M. S., Gingras, A., et al. (2021) · eLife · doi:10.7554/elife.62857 · Cited by 62 · see citing works

Dual roles of yes-associated protein (YAP) in colorectal cancer

Ou, C., Sun, Z., Li, S., Li, G., Li, X., & Ma, J. (2017) · Oncotarget · doi:10.18632/oncotarget.20155 · Cited by 62 · see citing works

Regulation of Myocardial Cell Growth and Death by the Hippo Pathway

Ikeda, S., & Sadoshima, J. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0476 · Cited by 61 · see citing works

YAP and the Hippo pathway in pediatric cancer

Ahmed, A. A., Mohamed, A. D., Gener, M., Li, W., & Taboada, E. M. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1295127 · Cited by 58 · see citing works

Soft Tissue Sarcoma Cancer Stem Cells: An Overview

Genadry, K. C., Pietrobono, S., Rota, R., & Linardic, C. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00475 · Cited by 55 · see citing works

FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner

Sun, H., Men, J., Liu, H.-Y., Liu, M.-Y., & Zhang, H. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108349 · Cited by 53 · see citing works

Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death

Guo, L., Ding, Z., Huang, N., Huang, Z., Zhang, N., & Xia, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1356507 · Cited by 51 · see citing works

Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis

Marquard, S., Thomann, S., Weiler, S. M. E., Bissinger, M., Lutz, T., Sticht, C., Tóth, M., Torre, C. D. L., Gretz, N., Straub, B. K., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00634-6 · Cited by 48 · see citing works

Targeting the Hippo pathway: Clinical implications and therapeutics

Ye, S., & Eisinger‐Mathason, T. S. K. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.025 · Cited by 45 · see citing works

TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR)

Ye, S., Liu, Y., Fuller, A. M., Katti, R., Ciotti, G. E., Chor, S., Alam, M. Z., Devalaraja, S., Lorent, K., WEBER, K. L., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0877 · Cited by 45 · see citing works

YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma

Rivera-Reyes, A., Ye, S., Marino, G. E., Egolf, S., Ciotti, G. E., Chor, S., Liu, Y., Posimo, J. M., Park, P. M. C., Pak, K., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1142-4 · Cited by 43 · see citing works

SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma

Isfort, I., Cyra, M., Elges, S., Kailayangiri, S., Altvater, B., Rössig, C., Steinestel, K., Grünewald, I., Huss, S., Eßeling, E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3553 · Cited by 43 · see citing works

The regulatory networks of the Hippo signaling pathway in cancer development

Wang, M., Dai, M., Wang, D., Xiong, W., Zeng, Z., & Guo, C. J. (2021) · Journal of Cancer · doi:10.7150/jca.62402 · Cited by 43 · see citing works

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

Tóth, M., Wehling, L., Thiess, L., Rose, F., Schmitt, J., Weiler, S. M. E., Sticht, C., Torre, C. D. L., Rausch, M., Albrecht, T., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08794-5 · Cited by 42 · see citing works

Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma

Lamar, J. M., Nehru, V. M., & Weinberg, G. L. (2018) · Cancers · doi:10.3390/cancers10070229 · Cited by 42 · see citing works

The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers

Kimura, H., Sada, R., Takada, N., Harada, A., Doki, Y., Eguchi, H., Yamamoto, H., & Kikuchi, A. (2021) · Oncogene · doi:10.1038/s41388-021-01860-z · Cited by 42 · see citing works

Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells

Wang, Y., Wu, J., Chen, H., Yang, Y., Xiao, C., Yi, X., Shi, C., Zhong, K., He, H., Li, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3445 · Cited by 38 · see citing works

Virtual screening for small-molecule pathway regulators by image-profile matching

Rohban, M. H., Fuller, A. M., Tan, C., Goldstein, J. T., Syangtan, D., Gutnick, A., Devine, A., Nijsure, M. P., Rigby, M., Sacher, J. R., et al. (2022) · Cell Systems · doi:10.1016/j.cels.2022.08.003 · Cited by 36 · see citing works

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone

Isfort, I., Elges, S., Cyra, M., Berthold, R., Renner, M., Mechtersheimer, G., Åman, P., Larsson, O., Ratner, N., Hafner, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56247-8 · Cited by 35 · see citing works

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma

Berthold, R., Isfort, I., Erkut, C., Heinst, L., Grünewald, I., Wardelmann, E., Kindler, T., Åman, P., Grünewald, T. G. P., Cidre‐Aranaz, F., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00394-7 · Cited by 34 · see citing works

Requirement for YAP1 signaling in myxoid liposarcoma

Trautmann, M., Cheng, Y., Jensen, P., Azoitei, N., Brunner, I., Hüllein, J., Slabicki, M., Isfort, I., Cyra, M., Berthold, R., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809889 · Cited by 32 · see citing works

Nuclear Import and Export of YAP and TAZ

Kofler, M., & Kapùs, A. (2023) · Cancers · doi:10.3390/cancers15204956 · Cited by 30 · see citing works

Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1

Zhang, H., Gui, T., Liu, R., Tong, K., Wu, C., Li, Z., Huang, X., Xu, Q., Yang, J., Tang, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03416-1 · Cited by 30 · see citing works

TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities

Garcia, K. C., Gingras, A., Harvey, K. F., & Tanas, M. R. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.08.002 · Cited by 30 · see citing works

The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective

Hu, X., Zhang, Y., Yu, H. N., Zhao, Y., Sun, X., Li, Q., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012173 · Cited by 30 · see citing works

Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment

Fuller, A. M., Pruitt, H. C., Liu, Y., Irizarry-Negron, V. M., Pan, H., Song, H., Devine, A., Katti, R., Devalaraja, S., Ciotti, G. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci167826 · Cited by 27 · see citing works

Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts

Wasinski, B. D., Sohail, A., Bonfil, R. D., Kim, S., Saliganan, A. D., Polin, L., Bouhamdan, M., Kim, H.-R. C., Prunotto, M., & Fridman, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-59028-w · Cited by 27 · see citing works

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 29 · see citing works

Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases

Liu, X., Du, S.-L., Miao, R., Wang, L., & Zhong, J. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09992-2 · Cited by 26 · see citing works

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma

Ito, T., Kohashi, K., Yamada, Y., Iwasaki, T., Maekawa, A., Kuda, M., Hoshina, D., Abe, R., Furue, M., & Oda, Y. (2016) · Journal of Cancer · doi:10.7150/jca.14461 · Cited by 24 · see citing works

A comprehensive evaluation of Hippo pathway silencing in sarcomas

Merritt, N. M., Fullenkamp, C. A., Hall, S. L., Qian, Q., Desai, C., Thomason, J., Lambertz, A. M., Dupuy, A. J., Darbro, B. W., & Tanas, M. R. (2018) · Oncotarget · doi:10.18632/oncotarget.25824 · Cited by 24 · see citing works

Fufang Xueshuantong protects retinal vascular endothelial cells from high glucose by targeting YAP

Xing, W., Song, Y., Li, H., Wang, Z., Wu, Y. L., Li, C., Wang, Y., Liu, Y., Wang, W., & Han, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109470 · Cited by 23 · see citing works

Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein

Mukhopadhyay, N. K., Chand, V., Pandey, A., Kopanja, D., Carr, J. R., Chen, Y., Liao, X., & Raychaudhuri, P. (2017) · Scientific Reports · doi:10.1038/srep46017 · Cited by 19 · see citing works

Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer

Blanchard, T. G., Czinn, S. J., Banerjee, V., Sharda, N., Bafford, A. C., Mubariz, F., Morozov, D., Passaniti, A., Ahmed, H., & Banerjee, A. (2019) · Cancers · doi:10.3390/cancers11020199 · Cited by 18 · see citing works

NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop

Hu, B., Zhou, S., Hu, X., Zhang, H., Lan, X., Li, M., Wang, Y., & Hu, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16409 · Cited by 18 · see citing works

Structure and function of MuvB complexes

Müller, G. A., Asthana, A., & Rubin, S. M. (2022) · Oncogene · doi:10.1038/s41388-022-02321-x · Cited by 17 · see citing works

DREAM a little dREAM of DRM: Model organisms and conservation of DREAM‐like complexes

Hoareau, M., Rincheval‐Arnold, A., Gaumer, S., & Guénal, I. (2023) · BioEssays · doi:10.1002/bies.202300125 · Cited by 14 · see citing works

WeCoMXP: Weighted Connectivity Measure Integrating Co-Methylation, Co-Expression and Protein-Protein Interactions for Gene-Module Detection

Mallik, S., & Bandyopadhyay, S. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2868348 · Cited by 15 · see citing works

The FOXM1/ATX signaling contributes to pancreatic cancer development.

Xie, D., Yu, S., Li, L., Quan, M., & Gao, Y. (2020) · PubMed Central · Cited by 15 · see citing works

Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma

Salguero‐Aranda, C., Olmedo-Pelayo, J., de Álava, E., Amaral, A. T., & Díaz‐Martín, J. (2022) · Cancers · doi:10.3390/cancers14246211 · Cited by 12 · see citing works

Injury promotes sarcoma development in a genetically and temporally restricted manner

Mater, D. V., Xu, E. S., Reddy, A., Añó, L., Sachdeva, M., Huang, W., Williams, N. T., Ma, Y., Love, C., Happ, L. E., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123687 · Cited by 13 · see citing works

FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy

Voigt, E. M., & Quelle, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713596 · Cited by 13 · see citing works

The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation

Shrestha, M., Ando, T., Chea, C., Sakamoto, S., Nishisaka, T., Ogawa, I., Miyauchi, M., & Takata, T. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz023 · Cited by 13 · see citing works

Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas

Desai, C., Thomason, J., Kohlmeyer, J. L., Reisetter, A. C., Ahirwar, P., Jahanseir, K., Leidinger, M., Ofori‐Amanfo, G. K., Fritchie, K., Velu, S. E., et al. (2021) · Oncotarget · doi:10.18632/oncotarget.27928 · Cited by 12 · see citing works

Unravelling undifferentiated soft tissue sarcomas: insights from genomics

Hames-Fathi, S., Nottley, S. W. G., & Pillay, N. (2021) · Histopathology · doi:10.1111/his.14446 · Cited by 12 · see citing works

Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication

Liu, K., Wehling, L., Wan, S., Weiler, S. M. E., Tóth, M., Ibberson, D., Marhenke, S., Ali, A., Lam, M., Guo, T., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05126-1 · Cited by 12 · see citing works

Increased Neutrophil Infiltration and Epithelial Cell Proliferation in Sinonasal Inverted Papilloma Compared to Contralateral Nasal Polyps

Wang, H., Zhou, J., Shi, L., Zhang, C., Li, W., Hu, L., Zhai, C., & Sun, X. (2022) · American Journal of Rhinology and Allergy · doi:10.1177/19458924221091691 · Cited by 12 · see citing works

RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2

Roßwag, S., Sleeman, J. P., & Thaler, S. (2021) · Cells · doi:10.3390/cells10112868 · Cited by 11 · see citing works

PVECs‐Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR‐induced Pulmonary Hypertension

Luo, X., Hang, C., Zhang, Z., Le, K., Ying, Y., Lv, Y., Yan, L., Huang, Y., Ye, L., Xu, X., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027177 · Cited by 11 · see citing works

Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma

Galoian, K. A., Luo, S., Qureshi, A. H., Patel, P., Price, R., Morse, A. S., Chailyan, G., Abrahamyan, S. S., & Temple, H. T. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.1010 · Cited by 12 · see citing works

Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis

Li, C., Peng, Z., Wang, Y., Lam, G., Nissen, N. N., Tang, J., Yuan, X., Lewis, M. S., Greene, M. I., Pandol, S. J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2020 · Cited by 11 · see citing works

Mechanism and therapeutic potential of hippo signaling pathway in type 2 diabetes and its complications

Zhao, Z., Wu, W.-G., Zhang, Q., Xing, T., Bai, Y., Li, S., Zhang, D., Che, H., & Guo, X. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117817 · Cited by 10 · see citing works

KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development

Cao, Y. W., Li, J., Zhang, G., Fang, H., Du, Y., & Liang, Y. (2024) · Communications Biology · doi:10.1038/s42003-023-05757-3 · Cited by 10 · see citing works

Cell-Cycle–Specific Autoencoding Improves Cluster Analysis of Cycling Cardiomyocytes

Nguyen, T. M., Nakada, Y., Wu, Y., Zhao, J., Garry, D. J., Sadek, H. A., & Zhang, J. J. (2024) · Stem Cells · doi:10.1093/stmcls/sxae016 · Cited by 9 · see citing works

MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness

Gonzalez‐Molina, J., Hahn, P., Falcão, R. M., Gultekin, O., Kokaraki, G., Zanfagnin, V., Lajus, T. B. P., Lehti, K., & Carlson, J. W. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13440 · Cited by 9 · see citing works

FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma

Zhang, P., Zhang, H., & Wang, Y. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03296-5 · Cited by 8 · see citing works

Syndecan-2 modulates the YAP pathway in epithelial-to-mesenchymal transition-related migration, invasion, and drug resistance in colorectal cancer

Yang, Y., Cao, Y. L., Wang, W. H., Shi, S. S., Zhang, Y. Y., Lv, B. B., Yang, W. W., Li, M., & Wei, D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20183 · Cited by 8 · see citing works

HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer

Lin, T.-I., Tseng, Y.-R., Dong, M.-J., Lin, C.-Y., Chung, W.-T., Liu, C., Tsai, Y., Huang, C.-C., Tseng, L., Chao, T., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01834-y · Cited by 7 · see citing works

PI3K regulates TAZ/YAP and mTORC1 axes that can be synergistically targeted

Garcia, K. C., Khan, A., Ghosh, K., Sinha, S., Scalora, N., DeWane, G., Fullenkamp, C. A., Merritt, N. M., Drebot, Y., Yu, S., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.191600 · Cited by 6 · see citing works

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas

Rytlewski, J. D., Scalora, N., Garcia, K. C., Tanas, M. R., Toor, F., Miller, B. J., Allen, B. G., Milhem, M. M., & Monga, V. (2021) · Cancers · doi:10.3390/cancers13040675 · Cited by 6 · see citing works

FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer

Rida, P. C. G., Baker, S., Saidykhan, A., Bown, I., & Jinna, N. (2024) · Cancers · doi:10.3390/cancers16183191 · Cited by 6 · see citing works

Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Freeland, J., Muñoz, M., O’Donnell, E. F., Langerman, J., Darrow, M. A., Bergonio, J., Suarez-Navarro, J., Thorpe, S. W., Canter, R. J., Randall, R. L., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1238 · Cited by 4 · see citing works

TP53INP2 promotes mitophagic degradation of YAP to impede dedifferentiated liposarcoma development

Wang, Y., Huang, Y., Wang, L., Chen, Z., Zhou, L., Xiang, F., Li, G., Yang, J., Chen, R., Xu, Q., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03358-4 · Cited by 3 · see citing works

Hippo signaling pathway in cervical cancer: insights into mechanisms and therapeutic potential

Sun, Y., Zhou, F., Zhong, X.-H., Lv, X., Liu, Y., Zhang, Y., Fine, R. D., & Li, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1662499 · Cited by 3 · see citing works

Differential Epigenetic Effects of BMI Inhibitor PTC-028 on Fusion-Positive Rhabdomyosarcoma Cell Lines from Distinct Metastatic Sites

Shields, C. E., Schnepp, R. W., & Haynes, K. A. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00244-9 · Cited by 3 · see citing works

Clinical and biological implications of Hippo pathway dysregulation in sarcomas

Kyriazoglou, A. I., Zakopoulou, R., Zagouri, F., Bamias, A., & Dimopoulos, M. A. (2018) · Forum of Clinical Oncology · doi:10.2478/fco-2018-0002 · Cited by 1 · see citing works

Induction Treatment in Sarcomas

Matter, M., Digklia, A., Gay, B., Bari, B. D., Diezi, M., & Raymond, É. (2016) · Springer eBooks · doi:10.1007/978-3-319-28773-7_27 · Cited by 1 · see citing works

Targeting eIF4A-dependent translation in genetically complex sarcoma

Kim, Y.-M., Mohan, P., Sehrawat, U., Seffar, E., De Queiroz, R. M., Chadalavada, K., Persaud, N., Okada, T., Kulkarni, A., Lin, J., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.192936

Genetic Screen in a Pre-Clinical Model of High-Grade Complex Karyotype Sarcoma Characterizes Drivers of Distinct Sarcoma Subtypes and Identifies New Therapeutic VulnerabilitiesPreprint

Freeland, J., Muñoz, M., O’Donnell, E. F., Langerman, J., Bergonio, J., Suarez-Navarro, J., Darrow, M. A., Thorpe, S. W., Canter, R. J., Randall, R. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.13.495815

YAP and collagen remodelling support cell proliferation and tumour aggressiveness in uterine leiomyosarcomaPreprint

Gonzalez‐Molina, J., Hahn, P., Falcão, R. M., Gultekin, O., Kokaraki, G., Zanfagnin, V., Lajus, T. B. P., Lehti, K., & Carlson, J. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497746

Mesenchymal Stem Cells and Sarcoma

Hatina, J., Kripnerová, M., Dejmek, J., Dolejšová, M., & Pešta, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00116-5

Additional file 1 of Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

Tóth, M., Wehling, L., Thiess, L., Rose, F., Schmitt, J., Weiler, S. M. E., Sticht, C., De La Torre, C., Rausch, M., Albrecht, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16755751

Additional file 3 of Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

Tóth, M., Wehling, L., Thiess, L., Rose, F., Schmitt, J., Weiler, S. M. E., Sticht, C., De La Torre, C., Rausch, M., Albrecht, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16755757

Abstract 960: Deregulation of the Hippo pathway in soft tissue sarcoma promotes FOXM1 expression and tumorigenesis

Eisinger‐Mathason, T. S. K., Mucaj, V., Biju, K., Nakazawa, M. S., Gohil, M., Cash, T. P., Yoon, S. S., Skuli, N., park, K. M., Gerecht, S., et al. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-960

Abstract B07: Regaining epigenetic control of the Hippo pathway to inhibit sarcomagenesis

Ye, S., Pak, K., Shah, J., Chor, S., Egolf, S., Marino, G. E., & Eisinger‐Mathason, T. S. K. (2018) · Clinical Cancer Research · doi:10.1158/1557-3265.sarcomas17-b07

The Hippo signal transduction pathway in soft tissue sarcomas

Mohamed, A. D., Tremblay, A., Murray, G. I., & Wackerhage, H. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.05.006 · Cited by 37 · see citing works

Abstract 3342: Hippo signaling promotes sarcomagenesis through the NF-kB pathway

Ye, S., Pak, K., Shah, J., Chor, S., Egolf, S., Marino, G. E., & Eisinger‐Mathason, T. S. K. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-3342

Abstract A02: YAP1 opposes differentiation in mesenchymal tumors

Liu, Y., Ciotti, G. E., & Eisinger‐Mathason, T. S. K. (2020) · Molecular Cancer Research · doi:10.1158/1557-3125.hippo19-a02